| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/1529-0131(199808)41:8<1388::AID-ART7>3.0.CO;2-F |
| P698 | PubMed publication ID | 9704636 |
| P2093 | author name string | Maini RN | |
| Hall MA | |||
| Feldmann M | |||
| Brennan FM | |||
| Hermann JA | |||
| P2860 | cites work | Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine | Q24298662 |
| The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 | ||
| Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis | Q28239197 | ||
| Functional expression of soluble human interleukin-11 (IL-11) receptor alpha and stoichiometry of in vitro IL-11 receptor complexes with gp130 | Q28298093 | ||
| Role of cytokines in rheumatoid arthritis | Q29620713 | ||
| Interleukin-11: a new cytokine critical for osteoclast development | Q34138407 | ||
| Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis | Q35132863 | ||
| Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples | Q35348875 | ||
| Enhancement of in vitro and in vivo antigen-specific antibody responses by interleukin 11. | Q36230765 | ||
| Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis | Q40587405 | ||
| Using inhibitors of metalloproteinases to treat arthritis. Easier said than done? | Q40684838 | ||
| Mediation of interleukin-11-dependent biological responses by a soluble form of the interleukin-11 receptor | Q41172054 | ||
| A highly sensitive quantitative bioassay for human interleukin-11. | Q41455237 | ||
| TNF inhibitors are produced spontaneously by rheumatoid and osteoarthritic synovial joint cell cultures: evidence of feedback control of TNF action. | Q41678435 | ||
| Immunoregulatory role of interleukin 10 in rheumatoid arthritis | Q42942352 | ||
| Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis | Q44064388 | ||
| Detection of transforming growth factor-beta in rheumatoid arthritis synovial tissue: lack of effect on spontaneous cytokine production in joint cell cultures | Q44487409 | ||
| P433 | issue | 8 | |
| P921 | main subject | inflammation | Q101991 |
| rheumatoid arthritis | Q187255 | ||
| interleukins | Q194908 | ||
| P304 | page(s) | 1388-1397 | |
| P577 | publication date | 1998-08-01 | |
| P1433 | published in | Arthritis & Rheumatology | Q4797636 |
| P1476 | title | Important immunoregulatory role of interleukin-11 in the inflammatory process in rheumatoid arthritis | |
| P478 | volume | 41 |
| Q39029629 | A review on interleukins: The key manipulators in rheumatoid arthritis |
| Q57811009 | Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis |
| Q53652096 | Bornyl acetate has an anti-inflammatory effect in human chondrocytes via induction of IL-11. |
| Q37272126 | Bovine lactoferricin-induced anti-inflammation is, in part, via up-regulation of interleukin-11 by secondary activation of STAT3 in human articular cartilage |
| Q36465497 | Cells of the synovium in rheumatoid arthritis. Macrophages |
| Q34587438 | Combination cytokine therapy: the next generation of rheumatoid arthritis therapy? |
| Q33417707 | Complex pattern of interleukin-11-induced inflammation revealed by mathematically modeling the dynamics of C-reactive protein |
| Q77627762 | Cytokine therapy in rheumatoid arthritis |
| Q44947229 | Cytokines |
| Q34830551 | Cytokines and anti-cytokine biologicals in autoimmunity: present and future |
| Q34637317 | Cytokines in rheumatoid arthritis |
| Q36364193 | Defining therapeutic targets by using adenovirus: blocking NF-kappaB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators |
| Q33331771 | Development of a lyophilization formulation that preserves the biological activity of the platelet-inducing cytokine interleukin-11 at low concentrations |
| Q35113678 | Functional characterization of W147A: a high-affinity interleukin-11 antagonist |
| Q53535370 | Gene expression profiles at different stages of collagen-induced arthritis. |
| Q36243407 | Host response modulation in the management of periodontal diseases |
| Q47657323 | IL-11 facilitates a novel connection between RA joint fibroblasts and endothelial cells |
| Q42425803 | IL-11 is a parietal cell cytokine that induces atrophic gastritis |
| Q50045633 | IL-27 - a double agent in the IL-6 family |
| Q34360546 | Immunotherapy for rheumatoid arthritis |
| Q24316211 | Interleukin-10 regulates TNF-alpha-converting enzyme (TACE/ADAM-17) involving a TIMP-3 dependent and independent mechanism |
| Q47941847 | Interleukin-11 and IL-17 and the pathogenesis of periodontal disease |
| Q28144068 | Interleukin-11 signals through the formation of a hexameric receptor complex |
| Q74046787 | Interleukin-4 inhibits interleukin-11 production by rheumatoid synovial cells |
| Q24806949 | Macrophages in rheumatoid arthritis |
| Q85071852 | Monocyte activation by apoptotic cells removal in systemic lupus erythematosus patients |
| Q39435692 | Murine J774 macrophages recognize LPS/IFN-g, non-CpG DNA or two-CpG DNA-containing sequences as immunologically distinct |
| Q26777974 | NF-κB and HIF crosstalk in immune responses |
| Q34309745 | New therapies in development for autoimmune diseases: their rationale for combination treatment |
| Q46935431 | Osteogenic effect of interleukin-11 and synergism with ascorbic acid in human periodontal ligament cells |
| Q34275978 | Pathogenesis of rheumatoid arthritis. The role of T cells and other beasts. |
| Q35084709 | Pathologic thrombopoiesis of rheumatoid arthritis |
| Q34276030 | Potential biologic agents for treating rheumatoid arthritis |
| Q24800647 | Results of a phase-I/II randomized, masked, placebo-controlled trial of recombinant human interleukin-11 (rhIL-11) in the treatment of subjects with active rheumatoid arthritis |
| Q77627732 | Role of pro-inflammatory cytokines in rheumatoid arthritis |
| Q36481079 | STAT3: a potential therapeutic target in dendritic cells for the induction of transplant tolerance |
| Q59296539 | Suppression of endotoxin-inducible cytokines in whole blood from human subjects following single dose of recombinant human interleukin-11 |
| Q34005615 | T lymphocyte and fibroblast interactions: the case of skin involvement in systemic sclerosis and other examples |
| Q34474506 | The correlation between increased serum concentrations of interleukin-6 family cytokines and disease activity in rheumatoid arthritis patients |
| Q57221296 | The effect of interleukin-11 on the progression of ligature-induced periodontal disease in the beagle dog |
| Q37873234 | The reprogrammed host: Chlamydia trachomatis-induced up-regulation of glycoprotein 130 cytokines, transcription factors, and antiapoptotic genes |
| Q35127430 | The role of the interleukin‐6 family of cytokines in inflammatory arthritis and bone turnover |
| Q27002391 | Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling |
| Q24801770 | Uterine extracellular matrix components are altered during defective decidualization in interleukin-11 receptor alpha deficient mice |
| Q58691977 | What Have We Learned about the Pathogenesis of Rheumatoid Arthritis from TNF-Targeted Therapy? |
Search more.